Competing interests KS declares nothing to disclose
Novo Nordisk transferring its semaglutide process to the new NC plant, or Lilly scaling tirzepatide from Indiana to Pennsylvania, are cases where tech transfer extends a process to a new site
doi: 10.1002/art.20811 76 BauerSJendroMCWadleAKleberSStennerFDinserRet al
Research from the STEP trials (semaglutide) and SURMOUNT trials (tirzepatide) demonstrates that GLP-1 agonists produce 1522% body weight loss in people with obesity, significantly outperforming older weight loss medications
PMID: 598342 Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F
Book your Peptide Discovery Call to learn which stack best fits your goals and start your journey toward leaner, stronger, glowing vitality